DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
155 hedge funds and large institutions have $778M invested in DIPLOMAT PHARMACY, INC. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 42 closing their positions.
42% more capital invested
Capital invested by funds: $547M → $778M (+$231M)
33% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 42
10% less call options, than puts
Call options by funds: $755K | Put options by funds: $841K
11% less funds holding
Funds holding: 174 → 155 (-19)
26% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$80M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$78.7M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$23.7M |
| 4 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
+$23.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$18.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$11.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$11.1M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$7.21M |
DPLO Hedge Fund Activity: Q1 2017 in Review
155 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2017, worth a combined $778M — up 42% from $547M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of DPLO and 31 opened new positions — a net loss of 11 holders — while 42 trimmed existing stakes and 56 added.
The largest buyer was BlackRock, adding an estimated $80M. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $18.8M sold.
- 155 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2017, down from 174 in Q4 2016.
- Funds reported $778M of DIPLOMAT PHARMACY, INC. stock for Q1 2017, up 42% quarter-over-quarter.
- 31 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2017 and 42 closed out, a net change of -11 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2017 was BlackRock, an estimated $80M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q1 2017 was Waddell & Reed Financial, an estimated $18.8M sold.
Based on aggregated 13F filings for Q1 2017.